glp-1 kidney disease news Discoveries in Medicine Updated evidence on cardiovascular and

Steven Davis and his team offer expert guidance tailored to your individual needs and goals

Theyre tools that can improve your overall health, not just help you see a lower number on the scale, she says

Betsy Dovec, MD, FACS, bariatric surgeon with HCA Florida Healthcare Dr

The pharmacokinetics of LY3437943 (retatrutide) support once-weekly administration due to an elimination half-life of approximately 6 days. Jastreboff AM et al., Nature Medicine, 2023 This extended half-life is made possible by attaching a fatty acid chain to the peptide, allowing it to bind to albumin a common protein in your blood that acts like a slow-release carrier

With paucity of high-quality data informing practice, anaesthetists must employ higher vigilance towards patients using GLP-1 agonists, acknowledging the already elevated risks these patients have for complex airways